Vijaya Polavaram, MD
Internal Medicine · Raleigh, NCNPI 1669513776
Payments from drug & device makers
Across 41 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$163
- Novo Nordisk$161
- Amarin Pharma, Inc.$58
- Boston Scientific$58
- AbbVie$56
- Pfizer$41
- plus $288 from 13 others
What the payments were for
- Food & beverage$824100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 6 | $163 |
| Novo Nordisk | 10 | $161 |
| Amarin Pharma, Inc. | 3 | $58 |
| Boston Scientific | 2 | $58 |
| AbbVie | 3 | $56 |
| Pfizer | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| Organogenesis Inc. | 1 | $36 |
| Exact Sciences | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Medtronic | 1 | $23 |
| Medicure Pharma Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Eisai Inc. | 1 | $12 |
How this compares
$824 in reported general payments places this provider in the 70th percentile of 3,302 internal medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl ErMemantine Hcl | 14 | $1,168 |
| Levothyroxine Sodium | 15 | $192 |
| Metformin Hcl | 18 | $186 |
| Metoprolol Succinate | 18 | $171 |
| Losartan Potassium | 19 | $170 |
| Levocetirizine Dihydrochloride | 12 | $120 |
| Amlodipine Besylate | 18 | $103 |
| Rosuvastatin Calcium | 12 | $95 |
| Metoprolol Tartrate | 16 | $80 |
| Glimepiride | 11 | $79 |
| Atorvastatin Calcium | 24 | $69 |
| Azithromycin | 15 | $37 |
| Prednisone | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Raleigh
- John RubinoRaleigh$13M
- Wayne HarperRaleigh$6.7M
- Bhakti PaulRaleigh$536K
- Clifford CurtisRaleigh$376K
- Manesh PatelDurham$27.2M
- Saad UsmaniCharlotte$16.2M
- Christina KennellyCharlotte$15.4M
- Adam DevoreDurham$11.8M
- Krishnakumar UdayakumarDurham$11M
- Sylvia ShoffnerCary$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.